OMM Treatment for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
The aim of this pilot study is to investigate the effect of Osteopathic Manipulative Medicine (OMM) in decreasing constipation symptoms in people with Parkinson's disease (PD). A second but optional aim is to determine if OMM changes the bacterial flora of the mouth and gut. OMM is a safe and gentle manual treatment provided by osteopathic physicians. All participants will receive OMM during the second half of the eleven week trial.
Who Is on the Research Team?
Jayme Mancini, D.O.
Principal Investigator
New York Institute of Technology- Academic Health Care Center
Are You a Good Fit for This Trial?
This trial is for individuals over 40 with Parkinson's disease who also suffer from constipation as defined by the Rome III criteria. It aims to help those looking for non-drug treatments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Observation
Surveys and optional stool tests are performed without OMM treatment to obtain baseline data
Treatment
Participants receive OMM treatment once a week for 4 weeks along with surveys and optional stool microbial tests
Follow-up
Participants are monitored for changes in constipation symptoms and bacterial flora after treatment
What Are the Treatments Tested in This Trial?
Interventions
- OMM treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
New York Institute of Technology
Lead Sponsor